Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Protean Select Pontus Dackmo | “Bavarian Nordic's neglected travel vaccine segment, particularly rabies and tick-borne encephalitis (TBE) treatments, provides a highly stable and defensive foundation that mitigates overall risk. TBE vaccines are benefiting from climate-driven demand, and margin improvements are anticipated in 2025 as production consolidation progresses as scheduled.” | BULL | Q4 2024 Jan 7, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
